How Long is Enough - Optimal Timing of Anti-HER2/neu Therapy in the Adjuvant Setting in Early Breast Cancer.

Auteurs : Pinto AC, de Azambuja E, Piccart-Gebhart M
Jaar : 2013
Journal : Breast Care (Basel)
Volume : 8(4)
Pagina's : 264-269